Gastrointestinal and hepatic side effects of potential treatment for COVID-19 and vaccination in patients with chronic liver diseases

doi:10.4254/wjh.v13.i12.1850

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 12

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5580)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

774

WORD

113

HTML

3431

Figures (1-1)

318

Tables (1-3)

257

Sum=4893

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

277

Download

410

Sum=687

Dec 27, 2021 (publication date) through Nov 4, 2024

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Hepatol. Dec 27, 2021; 13(12): 1850-1874
Published online Dec 27, 2021. doi: 10.4254/wjh.v13.i12.1850

Full Size Figure Download Figure

Figure 1 The mechanism of potential treatment of coronavirus disease 2019. ACE: Angiotensin-converting enzyme; IL-6: Interleukin-6.

Citation: Law MF, Ho R, Law KWT, Cheung CKM. Gastrointestinal and hepatic side effects of potential treatment for COVID-19 and vaccination in patients with chronic liver diseases. World J Hepatol 2021; 13(12): 1850-1874
URL: https://www.wjgnet.com/1948-5182/full/v13/i12/1850.htm
DOI: https://dx.doi.org/10.4254/wjh.v13.i12.1850